Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2020 Filed Aug 3, 2020 21:13 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 4,440 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-20-022573 · form4.xml · derivative · entry 3 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,440 Underlying: Common Stock · 4,440 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 21:13 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
SaleCommon Stock | 4,440 | $84.57 | $375,477.48 |
DisclosureSEC source: 0001127602-20-022573 · form4.xml · nonDerivative · entry 2 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,861 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.52 to $86.085. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 21:13 UTC |
SHAGORY PETER KEVP, STRAT & CORP DEVT
|
Exercise / conversionCommon Stock | 4,440 | $39.87 | $177,022.80 |
DisclosureSEC source: 0001127602-20-022573 · form4.xml · nonDerivative · entry 1 SHAGORY PETER K · CIK 0001398627 · EVP, STRAT & CORP DEVT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 20:12 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GiftCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-022548 · form4.xml · nonDerivative · entry 4 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,580 Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 20:12 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-022548 · form4.xml · nonDerivative · entry 3 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · daughter Disclosed balance after: 300 Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 20:12 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-022548 · form4.xml · nonDerivative · entry 2 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,180 Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 20:12 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
SaleCommon Stock | 4,349 | $82.66 | $359,488.34 |
DisclosureSEC source: 0001127602-20-022548 · form4.xml · nonDerivative · entry 1 JONAS DANIEL · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,280 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.40 to $84.30. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| June 30, 2020 Filed Jul 8, 2020 01:23 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
GrantCommon Stock | 24 | $68.39 | $1,641.36 |
DisclosureSEC source: 0000950123-20-006788 · doc4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,975 Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 21:25 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 18,000 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-20-019149 · form4.xml · derivative · entry 7 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 18,000 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 21:25 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 23,360 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-20-019149 · form4.xml · derivative · entry 6 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,840 Underlying: Common Stock · 23,360 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 21:25 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
SaleCommon Stock | 9,919 | $82.02 | $813,556.38 |
DisclosureSEC source: 0001127602-20-019149 · form4.xml · nonDerivative · entry 5 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,951 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.56 to $82.74. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 21:25 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
Tax withholdingCommon Stock | 13,167 | $81.03 | $1,066,922.01 |
DisclosureSEC source: 0001127602-20-019149 · form4.xml · nonDerivative · entry 4 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,870 Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 21:25 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
Exercise / conversionCommon Stock | 18,000 | $41.93 | $754,740.00 |
DisclosureSEC source: 0001127602-20-019149 · form4.xml · nonDerivative · entry 3 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 21:25 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
Tax withholdingCommon Stock | 16,555 | $81.29 | $1,345,755.95 |
DisclosureSEC source: 0001127602-20-019149 · form4.xml · nonDerivative · entry 2 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,037 Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 21:25 UTC |
Ruiz-Caban WilfredoEVP QA, RA and Operations
|
Exercise / conversionCommon Stock | 23,360 | $39.87 | $931,363.20 |
DisclosureSEC source: 0001127602-20-019149 · form4.xml · nonDerivative · entry 1 Ruiz-Caban Wilfredo · CIK 0001652949 · EVP QA, RA and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:40 UTC |
Workman John LDirector
|
GrantOptions To Purchase Common Stock · Derivative | 1,843 | $0.00 Strike: $73.94 | $0.00 |
DisclosureSEC source: 0001127602-20-018666 · form4.xml · derivative · entry 4 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,843 Underlying: Common Stock · 1,843 shares Expires 2030-06-01 F3 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:40 UTC |
Workman John LDirector
|
GrantRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018666 · form4.xml · derivative · entry 3 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:40 UTC |
Workman John LDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018666 · form4.xml · derivative · entry 2 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:40 UTC |
Workman John LDirector
|
Exercise / conversionCommon Stock | 1,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018666 · form4.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:38 UTC |
TRYNISKI MARK EDirector
|
GrantOptions To Purchase Common Stock · Derivative | 1,843 | $0.00 Strike: $73.94 | $0.00 |
DisclosureSEC source: 0001127602-20-018664 · form4.xml · derivative · entry 4 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,843 Underlying: Common Stock · 1,843 shares Expires 2030-06-01 F3 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:38 UTC |
TRYNISKI MARK EDirector
|
GrantRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018664 · form4.xml · derivative · entry 3 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:38 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,876 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018664 · form4.xml · derivative · entry 2 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,876 shares Expires 2029-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:38 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionCommon Stock | 1,876 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018664 · form4.xml · nonDerivative · entry 1 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:37 UTC |
Schwarzentraub Barbara JDirector
|
GrantOptions To Purchase Common Stock · Derivative | 1,843 | $0.00 Strike: $73.94 | $0.00 |
DisclosureSEC source: 0001127602-20-018663 · form4.xml · derivative · entry 2 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,843 Underlying: Common Stock · 1,843 shares Expires 2030-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:37 UTC |
Schwarzentraub Barbara JDirector
|
GrantRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018663 · form4.xml · derivative · entry 1 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:35 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018662 · form4.xml · derivative · entry 3 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 300 shares Expires 2023-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a seven year period with 14% of the RSU's vesting in the first through the fifth year after the grant date and 15% vesting in the sixth and seventh year. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:35 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Tax withholdingCommon Stock | 147 | $73.94 | $10,869.18 |
DisclosureSEC source: 0001127602-20-018662 · form4.xml · nonDerivative · entry 2 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,881 Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:35 UTC |
Pelletier Johonna MarieTreasurer and VP, Tax
|
Exercise / conversionCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018662 · form4.xml · nonDerivative · entry 1 Pelletier Johonna Marie · CIK 0001741585 · Treasurer and VP, Tax 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,028 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:31 UTC |
Farkas CharlesDirector
|
GrantOptions To Purchase Common Stock · Derivative | 1,843 | $0.00 Strike: $73.94 | $0.00 |
DisclosureSEC source: 0001127602-20-018660 · form4.xml · derivative · entry 4 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,843 Underlying: Common Stock · 1,843 shares Expires 2030-06-01 F3 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:31 UTC |
Farkas CharlesDirector
|
GrantRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018660 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:31 UTC |
Farkas CharlesDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018660 · form4.xml · derivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:31 UTC |
Farkas CharlesDirector
|
Exercise / conversionCommon Stock | 1,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018660 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:33 UTC |
Lande Jerome J.Director
|
GrantOptions To Purchase Common Stock · Derivative | 1,843 | $0.00 Strike: $73.94 | $0.00 |
DisclosureSEC source: 0001127602-20-018661 · form4.xml · derivative · entry 4 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,843 Underlying: Common Stock · 1,843 shares Expires 2030-06-01 F3 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:33 UTC |
Lande Jerome J.Director
|
GrantRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018661 · form4.xml · derivative · entry 3 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:33 UTC |
Lande Jerome J.Director
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018661 · form4.xml · derivative · entry 2 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and were subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs otherwise generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:33 UTC |
Lande Jerome J.Director
|
Exercise / conversionCommon Stock | 1,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018661 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:30 UTC |
Council LaVerne HDirector
|
GrantOptions To Purchase Common Stock · Derivative | 1,843 | $0.00 Strike: $73.94 | $0.00 |
DisclosureSEC source: 0001127602-20-018659 · form4.xml · derivative · entry 2 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,843 Underlying: Common Stock · 1,843 shares Expires 2030-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:30 UTC |
Council LaVerne HDirector
|
GrantRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018659 · form4.xml · derivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:28 UTC |
Concannon BrianDirector
|
GrantOptions To Purchase Common Stock · Derivative | 1,843 | $0.00 Strike: $73.94 | $0.00 |
DisclosureSEC source: 0001127602-20-018657 · form4.xml · derivative · entry 4 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,843 Underlying: Common Stock · 1,843 shares Expires 2030-06-01 F3 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:28 UTC |
Concannon BrianDirector
|
GrantRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018657 · form4.xml · derivative · entry 3 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:28 UTC |
Concannon BrianDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018657 · form4.xml · derivative · entry 2 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:28 UTC |
Concannon BrianDirector
|
Exercise / conversionCommon Stock | 1,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018657 · form4.xml · nonDerivative · entry 1 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:27 UTC |
Bronson David M.Director
|
GrantOptions To Purchase Common Stock · Derivative | 1,843 | $0.00 Strike: $73.94 | $0.00 |
DisclosureSEC source: 0001127602-20-018655 · form4.xml · derivative · entry 4 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,843 Underlying: Common Stock · 1,843 shares Expires 2030-06-01 F3 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:27 UTC |
Bronson David M.Director
|
GrantRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018655 · form4.xml · derivative · entry 3 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:27 UTC |
Bronson David M.Director
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018655 · form4.xml · derivative · entry 2 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 ended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:27 UTC |
Bronson David M.Director
|
Exercise / conversionCommon Stock | 1,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018655 · form4.xml · nonDerivative · entry 1 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,442 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:25 UTC |
Aronson Martha GoldbergDirector
|
GrantOptions To Purchase Common Stock · Derivative | 1,843 | $0.00 Strike: $73.94 | $0.00 |
DisclosureSEC source: 0001127602-20-018654 · form4.xml · derivative · entry 4 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,843 Underlying: Common Stock · 1,843 shares Expires 2030-06-01 F3 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:25 UTC |
Aronson Martha GoldbergDirector
|
GrantRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018654 · form4.xml · derivative · entry 3 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,521 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:25 UTC |
Aronson Martha GoldbergDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018654 · form4.xml · derivative · entry 2 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 19:25 UTC |
Aronson Martha GoldbergDirector
|
Exercise / conversionCommon Stock | 1,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-018654 · form4.xml · nonDerivative · entry 1 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.